Cardiovascular benefits of probiotics: a review of experimental and clinical studies

Food & Function
Ram Mohan ThusharaMohammed H Moghadasian

Abstract

The microbiota inhabiting the human gastro-intestinal tract is reported to have a significant impact on the health of an individual. Recent findings suggest that the microbial imbalance of the gut may play a role in pathogenesis of cardiovascular diseases (CVD). Therefore, several studies have delved into the aspect of altering gut microbiota with probiotics as an approach to prevent and/or treat CVD. The World Health Organization defines probiotics as live microorganisms that, when consumed in adequate amounts, have a positive influence on the individual's health. The present review focuses on strategies of human dietary intervention with probiotic strains and their impact on cardiovascular risk factors like hypercholesterolemia, hypertension, obesity and type-2 diabetes. Accumulating evidence shows probiotics to lower low density lipoproteins (LDL)-cholesterol and improve the LDL/high density lipoproteins (HDL) ratio, as well as lower blood pressure, inflammatory mediators, blood glucose levels and body mass index. Thus, probiotics have the scope to be developed as dietary supplements with potential cardiovascular health benefits. However, there is not only ambiguity regarding the exact strains and dosages of the probiotics t...Continue Reading

References

Mar 1, 1977·Atherosclerosis·G V Mann
Nov 1, 1996·The American Journal of Clinical Nutrition·Y HataT Takano
Aug 1, 1997·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·T MatsuzakiT Yokokura
May 8, 1999·The American Journal of Clinical Nutrition·M D Collins, G R Gibson
Jul 10, 1999·Die Nahrung·N Yamamoto, T Takano
Apr 4, 2000·European Journal of Clinical Nutrition·L Agerholm-LarsenA Astrup
Mar 29, 2001·Journal of the American Dietetic Association·L Kopp-Hoolihan
Sep 5, 2002·European Journal of Clinical Nutrition·G KiesslingG Jahreis
Mar 26, 2005·Science·Fredrik BäckhedJeffrey I Gordon
Aug 12, 2005·Journal of the American College of Nutrition·Kotaro AiharaYasunori Nakamura
May 16, 2006·Journal of Applied Microbiology·S ParvezH-Y Kim
Jun 3, 2006·Science·Steven R GillKaren E Nelson
Dec 22, 2006·Nature·Ruth E LeyJeffrey I Gordon
Feb 22, 2007·The Journal of Nutrition·Takeshi MatsuzakiTeruo Yokokura
Oct 30, 2007·Atherosclerosis·Jean BismuthChangyi Chen
Jan 10, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mary Ellen Sanders
Apr 3, 2008·Mayo Clinic Proceedings·John K DiBaiseBruce E Rittmann
May 29, 2008·World Journal of Gastroenterology : WJG·Riina-A KekkonenRiitta Korpela
Mar 31, 2009·Gastroenterology·Herbert TilgArthur Kaser
May 16, 2009·Current Pharmaceutical Design·Patrice D Cani, Nathalie M Delzenne
May 23, 2009·Journal of the American College of Cardiology·Carl J LavieHector O Ventura
Oct 30, 2009·International Journal of Molecular Sciences·Huey-Shi LyeMin-Tze Liong
Jan 27, 2010·The British Journal of Nutrition·Haleh Sadrzadeh-YeganehMaryam Chamary
Jul 1, 2009·Journal of Cutaneous and Aesthetic Surgery·Rajiv Saini Sugandha
May 17, 2011·Annual Review of Nutrition·Nathalie M Delzenne, Patrice D Cani
Dec 2, 2011·Nutrition·Hanie S EjtahedVahid Mofid
May 23, 2012·Experimental Diabetes Research·Manoj KumarHariom Yadav
Dec 12, 2012·Diabetes/metabolism Research and Reviews·Harsh PanwarSunita Grover
Jul 16, 2013·Current Opinion in Clinical Nutrition and Metabolic Care·Eibhlís M O'Connor
Nov 6, 2013·Critical Reviews in Food Science and Nutrition·Bruno EbelPatrick Gervais
Apr 1, 2014·FEBS Letters·Calum J WalshPaul D Cotter
Apr 23, 2014·Nature Reviews. Gastroenterology & Hepatology·Stephen M Collins
Aug 16, 2014·World Journal of Diabetes·Iciar Martín-TimónFrancisco Javier Del Cañizo-Gómez

❮ Previous
Next ❯

Citations

Oct 22, 2016·Frontiers in Physiology·José L de Brito AlvesLuciano Pirola
Mar 21, 2017·Current Hypertension Reports·Iñaki Robles-VeraJuan Duarte
Jan 23, 2017·Ageing Research Reviews·Alexander M VaisermanFrancesco Marotta
Jul 21, 2017·Beneficial Microbes·G ReidS van Hemert
Feb 24, 2017·Arteriosclerosis, Thrombosis, and Vascular Biology·Kazuhiro NakayaKatsunori Ikewaki
Jun 5, 2019·Cardiovascular Research·Themistoklis KatsimichasDimitris Tousoulis
Feb 2, 2019·Current Pharmaceutical Design·Michele ScognamiglioClaudio Napoli
May 4, 2017·Current Medicinal Chemistry·Maria De AngelisMarco Gobbetti
Nov 15, 2017·Current Opinion in Lipidology·Kazuhiro Nakaya, Katsunori Ikewaki
Aug 2, 2018·Applied Microbiology and Biotechnology·Muhammad Shahid Riaz RajokaJunling Shi
Jun 16, 2019·Applied Microbiology and Biotechnology·Adil HassanGuixue Wang
May 22, 2020·Critical Reviews in Food Science and Nutrition·Judit CompanysVicente Pascual
Jun 6, 2018·Frontiers in Physiology·Leandro R MarquesDaniela C Gonçalves
Oct 17, 2017·Cellular and Molecular Life Sciences : CMLS·Aurelia SantoroClaudio Franceschi
Sep 27, 2018·European Journal of Nutrition·Jesús Sanchis-ChordàPilar Codoñer-Franch
Apr 10, 2019·Nutrients·Despoina E KiousiAlex Galanis
Dec 9, 2020·International Journal of Molecular Sciences·Małgorzata SzczukoMaciej Ziętek
May 11, 2020·The Journal of Nutritional Biochemistry·Jun ZhouJia-Sheng Wang
Apr 1, 2021·Archives of Medical Research·Shilia Jacob KurianMahadev Rao
May 1, 2021·International Journal of Environmental Research and Public Health·Andrea PiccioniFrancesco Franceschi
May 6, 2021·International Journal of Molecular Sciences·Gopi BattineniSeyed Khosrow Tayebati
Sep 21, 2021·Frontiers in Microbiology·P R ChandhniSunita Grover
Oct 30, 2021·Microbial Biotechnology·Roshan KumarRup Lal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Risk Reduction

Prevention of cardiovascular disease is an important health initiative. Risk reduction including physical activity, smoking cessation, diet, blood pressure lowering drugs and pharmacotherapy. Here is the latest research on cardiovascular risk reduction.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Related Papers

Critical Reviews in Food Science and Nutrition
Bruno EbelPatrick Gervais
Nestlé Nutrition Workshop Series. Paediatric Programme
Bengt Björkstén
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology
Shih-Jin PanChih-Hsing Hung
© 2022 Meta ULC. All rights reserved